You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Omalizumab

Showing 26 - 50 of 256
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Food Allergy Trial in Odense C (Omalizumab Injection)

Active, not recruiting
  • Food Allergy
  • Omalizumab Injection
  • Odense C, Funen, Denmark
    Odense Research Center for Anaphylaxis, Allergy Center
Sep 20, 2022

Peanut Allergy, Food Allergy Trial in United States (Omalizumab, )

Active, not recruiting
Has Results
  • Peanut Allergy
  • Food Allergy
  • Omalizumab
  • placebo
  • Stanford, California
  • +3 more
Jan 11, 2022

Moderate-to-severe Allergic Asthma Trial in United States (Omalizumab)

Terminated
Has Results
  • Moderate-to-severe Allergic Asthma
  • Omalizumab
  • Rolling Hills Estates, California
  • +11 more
Feb 16, 2022

Bullous Pemphigoid Trial in Sacramento (Rituximab combined with Omalizumab)

Not yet recruiting
  • Bullous Pemphigoid
  • Rituximab combined with Omalizumab
  • Sacramento, California
    University of California, Davis, Department of Dermatology
Aug 16, 2021

Asthma Trial in Hangzhou (JYB1904, Omalizumab, JYB1904 Placebo)

Active, not recruiting
  • Asthma
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Oct 23, 2022

Healthy Trial in Mahesana (Omalizumab 150mg)

Recruiting
  • Healthy
  • Omalizumab 150mg
  • Mahesana, Gujarat, India
    Registered BE centre
Nov 4, 2022

Using Real-world Evidence (MORRE) Study

Recruiting
  • Asthma
    • Denver, Colorado
      National Jewish Health
    Jun 21, 2021

    Sinusitis Trial in Beijing (Mometasone furoate nasal spray hormone, Mometasone furoate nasal spray hormone + oral hormone,

    Recruiting
    • Sinusitis
    • Mometasone furoate nasal spray hormone
    • +2 more
    • Beijing, Beijing, China
      Beijing Tongren Hospital
    May 21, 2022

    Idiopathic Angioedema Trial in Madison (Omalizumab, Placebos)

    Completed
    Has Results
    • Idiopathic Angioedema
    • Omalizumab
    • Placebos
    • Madison, Wisconsin
      UW Madison
    Oct 21, 2021

    Autism Spectrum Disorder, Atopy Trial in Boston (Omalizumab Injection [Xolair])

    Withdrawn
    • Autism Spectrum Disorder
    • Atopy
    • Omalizumab Injection [Xolair]
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Aug 11, 2021

    Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Korea, Republic of (YH35324, Placebo, Omalizumab)

    Completed
    • Atopic Healthy Subjects
    • Adult Subjects With Mild Allergic Diseases
    • Suwon-si, Gyeonggi-do, Korea, Republic of
    • +3 more
    Jan 26, 2023

    Severe Allergic Asthma Trial in Taoyuan (Nocturnal Temperature Controlled Laminar Flow Device, None Device)

    Completed
    • Severe Allergic Asthma
    • Nocturnal Temperature Controlled Laminar Flow Device
    • None Device
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital
    Jun 8, 2021

    Chronic Urticaria Trial in United States (TEV-45779, XOLAIR® Injection)

    Recruiting
    • Chronic Urticaria
    • TEV-45779
    • XOLAIR® Injection
    • Bakersfield, California
    • +8 more
    Dec 16, 2021

    Healthy Volunteers Trial in Grafton, Christchurch (Omalizumab Prefilled Syringe)

    Recruiting
    • Healthy Volunteers
    • Omalizumab Prefilled Syringe
    • Grafton, Auckland, New Zealand
    • +1 more
    Apr 19, 2022

    Seasonal Allergic Rhinitis Trial in Beijing (Omalizumab)

    Completed
    • Seasonal Allergic Rhinitis
    • Omalizumab
    • Beijing, Beijing, China
      Beijing Tongren Hospital
    Jan 26, 2021

    Dermatitis, Atopic Trial in Spain (Ciclosporin)

    Recruiting
    • Dermatitis, Atopic
    • Badalona, Barcelona, Spain
    • +8 more
    Jan 5, 2023

    Chronic Spontaneous Urticaria Trial in Warszawa (CT-P39, EU-approved Xolair)

    Recruiting
    • Chronic Spontaneous Urticaria
    • CT-P39
    • EU-approved Xolair
    • Warszawa, Poland
      Klinika Ambroziak ESTEDERM
    Aug 25, 2021

    Allergic Disease, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria Trial in Seongnam-si, Suwon-si, Seoul (YH35324,

    Recruiting
    • Allergic Disease
    • +3 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +4 more
    Jul 24, 2023

    Allergic Bronchopulmonary Aspergillosis Trial (Prednisone tablet, itraconazole, Omalizumab)

    Not yet recruiting
    • Allergic Bronchopulmonary Aspergillosis
    • Prednisone tablet
    • +2 more
    • (no location specified)
    Nov 19, 2021

    Chronic Urticaria Trial in Denver (Omalizumab)

    Completed
    Has Results
    • Chronic Urticaria
    • Omalizumab
    • Denver, Colorado
      University of Colorado Hospital
    Nov 10, 2020

    Asthma, Allergic Rhinitis, Atopic Dermatitis Trial in Sacramento (Omalizumab, Placebo)

    Completed
    Has Results
    • Asthma
    • +2 more
    • Omalizumab
    • Placebo
    • Sacramento, California
      UC Davis Department of Dermatology
    Jun 21, 2021

    Chronic Rhinosinusitis With Nasal Polyps, Asthma Trial in Worldwide (Dupilumab, Omalizumab, Placebo)

    Recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Asthma
    • Tucson, Arizona
    • +65 more
    Jul 12, 2022

    Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Seongnam-si, Suwon-si, Seoul (YH35324, Placebo,

    Recruiting
    • Atopic Healthy Subjects
    • Adult Subjects With Mild Allergic Diseases
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +3 more
    Nov 11, 2022

    Symptomatic Dermographism Trial in Freiburg, Mainz (Omalizumab, Placebo)

    Completed
    Has Results
    • Symptomatic Dermographism
    • Omalizumab
    • Placebo
    • Freiburg, Germany
    • +1 more
    Oct 9, 2020

    Chronic Spontaneous Urticaria Trial (SYN008, Omalizumab for injection)

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • SYN008
    • Omalizumab for injection
    • (no location specified)
    Jun 22, 2021